Pope Leo early-stage adenocarcinoma is a reminder that lung nodules often cause no symptoms and that people who never smoked can get lung cancer.
News|Articles|December 29, 2024
Top 5 Obesity Articles of 2024
Author(s)MHE Staff
Here are the top performing articles about obesity published this year on Managed Healthcare Executive.
Advertisement
1. GLP-1 Tiering Agreement Reached, Says Optum Rx President
Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president. Optum officials said later that the negotiations were still ongoing.
2. Diabetes Weight Loss Drugs Could be Linked to Reduced Risk of MS, Study Finds
Drug repurposing has recently emerged as an attractive pathway for developing new treatments due to its relatively fast and cost-efficient trajectory. Because obesity and MS share inflammatory properties, researchers used data from the FDA Adverse Event Reporting System to investigate the association between weight loss-inducing drugs and MS.
3. GLP-1 Drugs for Obesity May Not Have to be All or Nothing
A simulation model projects there could savings if patients are switched to lower cost drugs or programs after initial weight loss using GLP-1 drugs.
4. Obesity, Heavy Smoking and Short Sleep Linked to Increased Risk of Multiple Myeloma
Those who suffer from obesity, heavy smoking and short sleep have a higher chance of developing mass spectrometry (MS) and monoclonal gammopathy of undetermined significance (MGUS), which can often lead to multiple myeloma.
5. Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients
The monthly price of the 2.5 mg Zepbound single-dose vial is $399 and the 5 mg dose is $549, which Lilly officials said is in line with the savings program for without insurance.
Advertisement
Related to this article
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.
Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, from safety huddles to discharges.
On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.
Research findings presented at CHEST meeting show COPD hospital readmission drops with discharge checklists and navigation. Other research suggests targeting readmission prevention efforts on patents discharged to post-acute facilities.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
2
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
3
Preventing hospital readmissions among patients with COPD. Here are some ideas on how to do that | CHEST 2026
4
Algia Pharma completes investigational drug toxicology study for non-opioid acute pain regimen AlgiaPak
5